Latest Stories
FreeGuest Editorial
Letter to the editor by The Philadelphia Inquirer’s James NeffWe see far too many patients with glioblastoma (GBM), an aggressive and almost always fatal malignant brain tumor.
ClinicalTrials & Tribulations
Over the past year, we have witnessed the awesome power of American pharmaceutical and biotechnology companies.
Guest Editorial
Funaro is a resident at Duke Pharmacy, Friedman is the James B. Powell Professor of Pediatric Oncology at Duke, and Weant is a clinical pharmacist in neuro-oncology at Duke Pharmacy.
